Leveraging a team of highly experienced individuals to facilitate unmet clinical needs

ReFormation Pharmaceuticals Corp is a Pharmaceutical company headquartered in Toronto, Canada with Research and Development operations at the University of Oxford. ReFormation focuses on an innovative approach to repair vital organs by targeting an endogenous trigger of repair (HMGB1).

ReFORMATION TARGETS

STEM CELL OPPORTUNITY

The Global Stem Cells Market was worth $5.17 Billion USD in 2017 and it is estimated to grow to $9.03 Billion USD by 2023 with a CAGR of 9.74% between 2017 and 2023.1